(18)F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma

BACKGROUND: The methylation status of the O(6)-methylguanine-DNA methyltransferase (MGMT) promoter has emerged as a favorable independent prognostic and predictive biomarker in glioma. This study aimed to build a radiomics signature based on (18)F-fluorodeoxyglucose (FDG) positron emission tomograph...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Imaging
Main Authors: Kong, Ziren, Lin, Yusong, Jiang, Chendan, Li, Longfei, Liu, Zehua, Wang, Yuekun, Dai, Congxin, Liu, Delin, Qin, Xuying, Wang, Yu, Liu, Zhenyu, Cheng, Xin, Tian, Jie, Ma, Wenbin
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6701097/
https://ncbi.nlm.nih.gov/pubmed/31426864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40644-019-0246-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados